CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Accounts Receivable, Allowance for Credit Loss, Recovery
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $934.00 thousand for the 3-month period ending 2024-03-30, per its 10-Q filed 2024-05-09.
Discontinued › Notes › and Others
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2024-05-09
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. accounts receivable, allowance for credit loss, recovery for the quarter ending 2024-03-30 was $934.00K, a 83.70% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. accounts receivable, allowance for credit loss, recovery for the quarter ending 2023-04-01 was $5.73M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. accounts receivable, allowance for credit loss, recovery for fiscal 2016 was $500.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 3 month | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month |
|---|---|---|
| 2024-03-30 | $934.00K 10-Q · filed 2024-05-09 | |
| 2023-04-01 | $5.73M 10-Q · filed 2024-05-09 | |
| 2016-12-31 | $500.00K 10-K · filed 2019-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |